Product Description
| Product Name | Cladribine |
| CAS | 4291-63-8 |
| EINECS | 636-978-6 |
| Assay | 99% |
| Appearance | White Powder |
| MF | C10H12ClN5O3 |
Cladribine is a white powder, Cladribine is a synthetic anti-cancer agent that also suppresses the immune system. Chemically, Cladribine mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase, which interferes with the cell's ability to process DNA. Cladribine is easily destroyed by normal cells except for blood cells, with the result that it produces relatively few side effects and results in very little non-target cell loss.
Cladribine is a synthetic anti-cancer agent that also suppresses the immune system. Chemically, Cladribine mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase, which interferes with the cell's ability to process DNA. Cladribine is easily destroyed by normal cells except for blood cells, with the result that it produces relatively few side effects and results in very little non-target cell loss.
Cladribine is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis) and multiple sclerosis.
Cladribine is used for the treatment of symptomatic hairy cell leukemia and is administered by injection.According to the Histiocytosis Association, cladribine is used to treat histiocytosis.
Clabridine can cause fetal harm when administered to a pregnant woman and is listed by the FDA as Pregnancy Category D; safety and efficacy in children has not been established.
China
